Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node

被引:4
作者
Hulvat, Melissa [1 ]
Rajan, Prabha [2 ]
Rajan, Elizabeth [2 ]
Sarker, Sharfi [1 ]
Schermer, Carol [1 ]
Aranha, Gerard [1 ]
Yao, Katharine [1 ]
机构
[1] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
关键词
D O I
10.1016/j.surg.2008.06.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Clinicians often rely on primary tumor characteristics to decide on adjuvant treatment for patients with breast cancer with isolated tumor cells (ITC) in the sentinel lymph node. The Purpose of this study was to determine if there is a significant difference in primary tumor characteristics between ITC and other nodal groups. Methods. Patients undergoing sentinel lymphadenectomy were divided into 3 groups: NO, no metastases, ITC, metastasis less than 0.2 mm; and micro- or macrometastases (MM), metastasis greater than 0.2 mm. The chi-square test and analysis of variance were used. Results. A total of 552 patients underwent sentinel lymphadenectomy; 197 (36%) had tumor-positive sentinel lymph nodes. Of these, 35 (18%) were classified as ITC and 162 (82%) as MM. When primary tumor characteristics were compared, the ITC group had significantly more lymphovascular invasion and higher proliferative rate than the M group (P < .05) and significantly less lymphovascular invasion, lower proliferative rate, and smaller tumor size (P < .05) than the MM group. There were no significant differences in the age, hormone receptor status, histologic type, or tumor grade among the patient groups. Conclusions. Proliferation and lymphovascular invasion of the primary tumor are significantly different between the ITC, NO, and MM groups suggesting that ITC tumors may have different biology than the NO or MM tumors.
引用
收藏
页码:518 / 524
页数:7
相关论文
共 37 条
[1]  
Baum M, 2002, LANCET, V359, P2131
[2]   Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma [J].
Bleiweiss, IJ ;
Nagi, CS ;
Jaffer, S .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2013-2018
[3]   Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study [J].
Bolster, Marieke J. ;
Peer, Petronella G. M. ;
Bult, Peter ;
Thunnissen, Frederik B. J. M. ;
Schapers, Rene F. M. ;
Meijer, Jos W. R. ;
Strobbe, Luc J. A. ;
van Berlo, Charles L. H. ;
Klinkenbijl, Jean H. G. ;
Beex, Louk V. A. M. ;
Wobbes, Theo ;
Tjan-Heijnen, Vivianne C. G. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :181-189
[4]  
BRAUN M, 2007, BREAST CANC RES TREA
[5]   Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection [J].
Calhoun, KE ;
Hansen, NM ;
Turner, RR ;
Giuliano, AE .
AMERICAN JOURNAL OF SURGERY, 2005, 190 (04) :588-591
[6]   Sentinel lymph node histopathology in breast cancer: Minimal disease versus artifact [J].
Carter, BA ;
Page, DL .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :1978-1979
[7]   Benign transport of breast epithelium into axillary lymph nodes after biopsy [J].
Carter, BA ;
Jensen, RA ;
Simpson, JF ;
Page, DL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) :259-265
[8]   Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry [J].
Chagpar, A ;
Middleton, LP ;
Sahin, AA ;
Meric-Bernstam, F ;
Kuerer, HM ;
Feig, BW ;
Ross, MI ;
Ames, FC ;
Singletary, SE ;
Buchholz, TA ;
Valero, V ;
Hunt, KK .
CANCER, 2005, 103 (08) :1581-1586
[9]   The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer [J].
Clahsen, PC ;
van de Velde, CJH ;
Duval, C ;
Pallud, C ;
Mandard, AM ;
Delobelle-Deroide, A ;
van den Broek, L ;
van de Vijver, MJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04) :356-363
[10]  
COCHRAN AJ, 2001, PROGR PATHOLOGY, V5, P45